日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Network medicine modeling of the m⁶A regulatory landscape identifies a KLF6-WTAP axis as a therapeutic target in pulmonary fibrosis.

网络医学模型揭示了调控格局,并将 KLF6-WTAP 轴确定为肺纤维化的治疗靶点。

Xu Chengyuan, Zhou Ziheng, Lin Yani, Zhang Siqi, Cai Shanshan, Li Bing, Wang Zhifang

Structural mechanism of H3K27 demethylation and crosstalk with heterochromatin markers

H3K27去甲基化的结构机制及其与异染色质标记的相互作用

Chien-Chu Lin ,Yani Zhao ,Caroline A Foley ,Aspen T Hawkins ,Lindsey I James ,Stephen V Frye ,Robert K McGinty

An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity

烯酰-ACP还原酶抑制剂NITD-916具有抗脓肿分枝杆菌活性。

Jia, Yaping; Fan, Junsheng; Tan, Zhili; Li, Anqi; He, Siyuan; Lin, Yani; Li, Juan; Zhang, Zhemin; Li, Bing; Chu, Haiqing

Endoplasmic reticulum stress in non-small cell lung cancer

非小细胞肺癌中的内质网应激

Li, Xiaodong; Hu, Fangning; Lu, Tong; Wu, Shuo; Ma, Guanqiang; Lin, Yani; Zhang, Hua

Erratum: Endoplasmic reticulum stress in non-small cell lung cancer

勘误:非小细胞肺癌中的内质网应激

Li, Xiaodong; Hu, Fangning; Lu, Tong; Wu, Shuo; Ma, Guanqiang; Lin, Yani; Zhang, Hua

Detection of leukemia gene fusions on DNA-level through targeted Next-Generation Sequencing

通过靶向二代测序在DNA水平上检测白血病基因融合

Chen, Bin; Gao, Zhihui; Chen, Long; Zhang, Hong; Lin, Yani; Li, Jing

Duplication of the Long Arm of Chromosome 3 Leads to MECOM Rearrangement in Acute Myeloid Leukemia

3号染色体长臂重复导致急性髓系白血病中的MECOM重排

Yang, Shaobin; Ma, Shiyang; Yan, Xiaoyan; Yao, Jingya; Lin, Yani

Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR

Ph阴性MPN患者JAK2、MPL或CALR非典型变异的临床实验室特征和基因突变谱

Wang, Zhanlong; Tian, Xin; Ma, Jinyu; Zhang, Yuhui; Ta, Wenru; Duan, Yifan; Li, Fengli; Zhang, Hong; Chen, Long; Yang, Shaobin; Liu, Enbin; Lin, Yani; Yuan, Weiping; Ru, Kun; Bai, Jie

[Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia]

[高三尖杉酯碱、阿糖胞苷、柔红霉素或伊达比星(HAD/HAI)作为新发急性髓系白血病诱导化疗的长期疗效]

Qin, Tiejun; Xu, Zefeng; Zhang, Yue; Lin, Yani; Ru, Kun; Fang, Liwei; Zhang, Hongli; Pan, Lijuan; Hu, Naibo; Qu, Shiqiang; Wang, Jingya; Xing, Ruixian; Xiao, Zhijian